Medifast (MED) Q4 Earnings and Revenues Beat Estimates

Company Performance - Medifast reported quarterly earnings of $0.10 per share, exceeding the Zacks Consensus Estimate of a loss of $0.27 per share, compared to earnings of $1.09 per share a year ago, representing an earnings surprise of 137.04% [1] - The company posted revenues of $119 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 7.70%, but down from $191.02 million year-over-year [2] - Over the last four quarters, Medifast has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Outlook - Medifast shares have declined approximately 8% since the beginning of the year, while the S&P 500 has gained 4% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.10 on revenues of $148.21 million, and for the current fiscal year, it is $0.51 on revenues of $566.19 million [7] Industry Context - The Zacks Industry Rank for Food - Miscellaneous, which includes Medifast, is currently in the bottom 27% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Medifast's stock performance [5]